Trademark Overview
On Thursday, July 3, 2025, a trademark application was filed for CITRYLL with the United States Patent and Trademark Office. The USPTO has given the CITRYLL trademark a serial number of 79433624. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 2, 2025. This trademark is owned by Citryll BV. The CITRYLL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease; antibodies for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease; antibodies for the prevention or treatment of autoimmune diseases; small molecules and synthetic peptides for the prevention and treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease
